Alzheimers Disease and other Cognitive Disorders
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Alzheimer's May Strike Women and Men in Different WaysHistory of Mental Illness Tied to Earlier Onset of Alzheimer's DiseaseAHA News: Black, Hispanic Families Hit Hardest by DementiaWhy Some 'Super Ager' Folks Keep Their Minds Dementia-FreeDementia Seen in Younger Adults Shows Even More Brain Damage Than Alzheimer'sToo Little Sleep Could Raise Your Dementia RiskSpecialist Care for Alzheimer's Is Tough to Find for Poorer, Rural AmericansTony Bennett's Struggle With Alzheimer's RevealedFluid-Filled Spaces in the Brain Linked to Worsening MemoryCOVID Vaccine Advised for Alzheimer's Patients, Their CaregiversAphasia Affects Brain Similar to Alzheimer's, But Without Memory LossCaregivers Feeling the Strain This Tough Holiday SeasonYears Before Diagnosis, People With Alzheimer's Lose Financial AcumenCould Dirty Air Help Speed Alzheimer's?Strong Sleeping Pills Tied to Falls, Fractures in Dementia PatientsAnxiety Might Speed Alzheimer's: StudyPre-Op 'Brain Games' Might Prevent Post-Op DeliriumDoes Hard Work Help Preserve the Brain?Staying Active as You Age Not a Guarantee Against DementiaSmog Tied to Raised Risk for Parkinson's, Alzheimer's DiseasePoor Brain Blood Flow Might Spur 'Tangles' of Alzheimer'sIs Apathy an Early Sign of Dementia?A-Fib Treatment Reduces Patients' Dementia RiskFall Risk Rises Even in Alzheimer's Early StagesPTSD May Be Tied to Greater Dementia RiskNew Research Links Another Gene to Alzheimer's RiskIs Rural Appalachia a Hotspot for Alzheimer's?Why Are Dementia Patients Getting Risky Psychiatric Drugs?Get Dizzy When Standing Up? It Could Be Risk Factor for DementiaCan Seniors Handle Results of Alzheimer's Risk Tests?More Education May Slow Start of Early-Onset Alzheimer'sUnder 50 and Overweight? Your Odds for Dementia Later May Rise9/11 First Responders Have Higher Odds for Alzheimer's: StudyCould the Flu Shot Lower Your Risk for Alzheimer's?Will Your Brain Stay Sharp Into Your 90s? Certain Factors Are KeyMany Americans With Dementia Live in Homes With GunsBrain's Iron Stores May Be Key to Alzheimer'sHormones May Explain Greater Prevalence of Alzheimer's in WomenMiddle-Age Obesity Linked to Higher Odds for DementiaCould Crohn's, Colitis Raise Dementia Risk?5 Healthy Steps to Lower Your Odds for Alzheimer'sCOVID-19 Brings New Challenges to Alzheimer's CaregivingAlzheimer's Gene Linked to Severe COVID-19 RiskHealthier Heart, Better Brain in Old AgeAHA News: Hearing Loss and the Connection to Alzheimer's Disease, DementiaBrain Plaques Signal Alzheimer's Even Before Other Symptoms Emerge: StudyCertain Gene Might Help Shield At-Risk People From Alzheimer'sHow to Connect With Nursing Home Patients in QuarantineHow to Ease Loved Ones With Alzheimer's Through the PandemicCaring for Dementia Patient During Pandemic? Try These Stress-Busting Tips
Questions and AnswersVideosLinksBook Reviews
Related Topics

Aging & Geriatrics
Memory Problems
Elder Care

Certain Gene Might Help Shield At-Risk People From Alzheimer's

HealthDay News
by By Amy Norton
HealthDay Reporter
Updated: Apr 13th 2020

new article illustration

MONDAY, April 13, 2020 (HealthDay News) -- People who carry a gene called APOE4 face an increased risk of Alzheimer's. But that effect may be lessened if they got luckier with a different gene, researchers have found.

Scientists have long known that the APOE gene is the strongest genetic influence over whether people develop Alzheimer's late in life. Those who carry a form of the gene called E4 have a higher-than-average risk.

However, not all APOE4 carriers develop Alzheimer's -- and it's important to understand what protects those people, said study co-author Dr. Michael Greicius, an associate professor of neurology at Stanford University School of Medicine in California.

Based on his team's findings, a lot may ride on another gene, called klotho. Among APOE4 carriers, those who also have a "protective" form of klotho are 30% less likely to develop Alzheimer's by age 80.

Neurologist Dr. Dena Dubal said it suggests that the klotho variant can help the brain "altogether avert harmful effects of APOE4."

Dubal is an associate editor of JAMA Neurology, which published the study online April 13. She authored an editorial accompanying the findings.

The klotho gene is named for a Greek Fate and daughter of Zeus, who was said to spin the thread of life. It's so-called because recent studies have revealed the gene to be important in healthy aging, in lab mice and in people.

"It's basically a longevity gene," said Greicius.

What's not clear, he said, is exactly how klotho counteracts some of the harm of APOE4. If researchers can figure that out, Greicius added, it could potentially lead to new treatments or ways to prevent Alzheimer's.

We all inherit two copies of every gene -- one from each parent. In the United States, about 25% of the population carries one copy of APOE4, and their Alzheimer's risk is three to four times higher than average, according to the U.S. National Institute on Aging. A small percentage carries two copies, and their risk is higher still.

With klotho, Greicius explained, it's best to inherit just one copy of the protective form. That seems to boost levels of klotho protein in the blood. What's more, people who carry one copy tend to live longer and healthier, versus those who carry either two copies or none.

It turns out that the ideal klotho scenario is just as common as the APOE4 gene variant: About one-quarter of Americans carry one copy of the protective form of the gene, according to Greicius.

For the current study, his team combed through publicly available research databases, collecting data on more than 20,000 people age 60 and up -- some with Alzheimer's, some with milder impairment, and some with intact thinking and memory skills.

Among APOE4 carriers, those who also had one copy of the protective klotho variant were 30% less likely to develop Alzheimer's by age 80. There was no evidence, however, that the klotho variant protected people who did not carry the APOE4 variant.

"That suggests to us there could be an interaction between the klotho variant and APOE4," Greicius said.

It will be important to understand what is going on, Dubal said. At this point, she noted, there are some clues from animal research: In lab mice, higher klotho levels boost brain function.

"Maybe klotho, along with a healthy lifestyle, could be an effective treatment for APOE4 carriers in staving off Alzheimer's," Dubal speculated. "We need more work down this pathway."

It does seem logical that raising klotho levels in the body could be beneficial, Greicius agreed. However, he stressed, no one knows if that's actually the case.

The findings raise another question: Should APOE4 carriers be tested for their klotho genotype? Greicius said he thinks more research is needed first.

That point was echoed by Rebecca Edelmayer, director of scientific engagement for the Alzheimer's Association.

"I don't think this is something you can talk to your doctor about today -- though it may be in future," Edelmayer said. She noted that researchers are continuing to dig into the genetics of Alzheimer's, and it may well turn out that other genes (and gene interactions) are key to the puzzle, too.

And then there are lifestyle measures: a healthy diet, exercise, controlling health conditions like high blood pressure and diabetes, and challenging the mind with mentally engaging activities. Research suggests that in general, those things can help protect the aging brain, Edelmayer said.

More information

The U.S. National Institute on Aging has more on the genetics of Alzheimer's.


Amazon Smile


Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.


powered by centersite dot net